FUNDAMENTALS
EdgeFII/DII
ASTERDMAster DM Healthcare
₹779.30+5.41%
Terminal
  • Overview
  • Price
  • Ratios
  • About
  • P&L
  • Balance
  • Cash flow
  • Holders
  • Actions
  • Peers
  • News
ASTERDMNSE · EquityHealthcare Services

Aster DM Healthcare

ISIN
INE914M01019
Instrument key
NSE_EQ|INE914M01019
Open in terminal Fundamentals cached for 6 hours
Last traded price
₹779.30+40.00 · +5.41%
Day rangecircuit ₹623.45 – ₹935.15
729.00
781.85

as of 21/11/2026, 11:29:11 am

Open
₹732.40
Day high
₹781.85
Day low
₹729.00
Prev. close
₹739.30
Volume
26.66 L
VWAP
₹770.06

On this page

Company

  • Overview
  • Price chart
  • Key ratios
  • About

Statements

  • Profit & loss
  • Balance sheet
  • Cash flow

Ownership

  • Shareholding
  • Corporate actions
  • Peers

Market

  • News

02/Price history

Price chart

6 months · daily candles. Hover the chart for the OHLC of any candle; the table below holds the same data row by row.

1D1W1M6M
1Y
5Y
MAX
Change · 6M
+2.64%
759.25 → 779.30
Period high
₹891.30
10/8/2026
Period low
₹638.00
23/10/2026
From high
-12.57%
+22.15% from low
Avg volume
16.77 L
21.30 Cr total
Volatility · ann.
30.0%
127 candles · 55 up / 71 down
20 Nov 2026O 732.40H 781.85L 729.00C 779.30Vol 26.66 L
SMA 20SMA 50Averages need 50 candles before they begin
Candle data127 rows of open, high, low, close and volumeShowHide
20 Nov 2026732.40781.85729.00779.30+6.40%52.8526.66 L
19 Nov 2026734.00740.45727.00739.30+0.72%13.453.74 L
18 Nov 2026739.40750.60728.00731.00-1.14%22.608.66 L
17 Nov 2026750.30756.25732.45737.95-1.65%23.809.45 L
16 Nov 2026723.35757.45722.70750.00+3.68%34.7514.80 L
13 Nov 2026735.90740.00718.60722.50-1.82%21.4010.57 L
12 Nov 2026724.20739.30715.20735.90+1.62%24.109.30 L
11 Nov 2026744.70744.70717.00724.20-2.75%27.7012.51 L
9 Nov 2026733.60746.65703.60733.50-0.01%43.0520.61 L
8 Nov 2026739.00771.95739.00749.35+1.40%32.9514.21 L

Historical price and volume data · Showing 1–10 of 127

1 / 13

03/Valuation & returns

Key ratios vs sector

Company value benchmarked against the sector median. The ratio set is sector specific — banks report NIM, CASA and Net NPA instead of EV/EBITDA.

P/E

Price ÷ earnings per share

120.5
Company
120.5
Sector
55.28

Worse than sector by 118%

P/B

Price ÷ book value per share

9.13
Company
9.13
Sector
3.05

Worse than sector by 199%

ROA

Net income ÷ total assets

3.22%
Company
3.22%
Sector
4.2%

Worse than sector by 23%

ROE

Net income ÷ shareholders' equity

7.11%
Company
7.11%
Sector
-31.98%

Better than sector by 122%

ROCE

EBIT ÷ capital employed

8.21%
Company
8.21%
Sector
11.89%

Worse than sector by 31%

Quick Ratio

Liquid assets ÷ current liabilities

1.9
Company
1.9
Sector
32.98

Worse than sector by 94%

EV/EBITDA

Enterprise value ÷ EBITDA

51.32
Company
51.32
Sector
23.22

Worse than sector by 121%

04/Business

About the company

Sector: Healthcare Services

Aster DM Healthcare Limited is an India-based healthcare service provider. The Company is operating in India with a presence across primary, secondary, tertiary, and quaternary healthcare through approximately 19 hospitals with 5,159 beds, 10 clinics, 203 pharmacies (Operated by Alfaone Retail Pharmacies Private Limited under brand license from Aster), and 262 labs and patient experience centers across five states in India. Its center of excellence includes oncology (AIIO), cardiac sciences, neurosciences, gastro sciences, integrated liver care, multi-organ transplant, orthopedics, obstetrics and gynecology, and pediatrics and neonatology. Its pharmacy offers various product categories, including prescription, OTC drugs, personal care and hygiene, feminine care, baby care, wellness, sports nutrition, surgical and disposables, and medical devices. Its labs deliver diagnostic services covering biochemistry, microbiology, hematology, clinical pathology, histopathology and cytogenetics.

Sector market cap (INR)
₹67,960 Cr

reported in crore

Sector market cap (USD)
$7.55B

reported in billion

Market capitalisation is reported at the sector-constituent level, not the standalone company level.

05/Profit & loss

Consolidated income statement

Annual figures in ₹ crore. Growth marked reported is provided; margins are derived.

YearlyQuarterly
ConsolidatedStandalone
Revenue · Mar 2026
₹4,769 Cr
+11.25% vs Mar 2025
Net profit · Mar 2026
₹427 Cr
-92.10% vs Mar 2025
Operating margin
11.9%
was 11.0%
Revenue CAGR · 4p
16.3%
profit -3.5% · op 42.8%
Filed order
Revenue4,7694,2873,7243,031
Revenue growthreported11.3%15.1%22.9%—
Operating profit570471261195
Operating profit growthreported20.9%80.3%33.6%—
Operating marginderived11.9%11.0%7.0%6.4%
Net profit4275,408212475
Net profit growthreported-92.1%2456.2%-55.5%—
Net marginderived9.0%126.2%5.7%15.7%
EPS — basic₹/share, annual7.52107.852.608.54

Figures in ₹ crore. Margin rows are computed from the reported values.

06/Balance sheet

Consolidated balance sheet

Only annual balance sheets are available — the quarterly filter does not apply here. Figures in ₹ crore; net worth is assets minus liabilities.

ConsolidatedStandalone
Total assets · Mar 2026
₹8,112 Cr
+22.79% YoY
Total liabilities
₹3,278 Cr
Net worth
₹4,834 Cr
Liabilities ÷ assets
40.4%
lower means a lighter balance sheet
Filed order
Total assets8,1126,60617,99114,881
Total liabilities3,2782,95512,96110,021
Net worthderived4,8343,6515,0304,860
Liabilities ÷ assetsderived40.4%44.7%72.0%67.3%
Asset growthderived22.8%-63.3%20.9%—

Figures in ₹ crore. Stacked chart height equals total assets.

Full annual line itemsNon-current & current assets, liabilities, equity capitalShowHide
Filed order
Non-Current Assets6,1644,7053,8269,960
Current Assets1,9481,90114,1654,922
Total Assets8,1126,60617,99114,881
Current Liabilities97987911,2884,655
Net Current Asset9691,0222,877266
Non-Current Liabilities2,2992,0761,6735,365
Equity Capital4,8343,6515,0304,860
Total Equity & Liabilities8,1126,60617,99114,881

Figures in ₹ crore unless the line item is per-share.

07/Cash flow

Consolidated cash flow

Annual only, in ₹ crore. Negative values are outflows, so healthy companies usually show positive operating and negative investing cash flow.

ConsolidatedStandalone
Operating · Mar 2026
₹656 Cr
+54.32% YoY
Investing
-₹288 Cr
Financing
-₹304 Cr
Free cash flow
₹368 Cr
operating + investing
Filed order
Operating activities6564251581,834
Operating changereported54.3%169.3%-91.4%—
Investing activities-2886,015-885-972
Investing changereported-104.8%779.9%9.0%—
Financing activities-304-6,3581,053-817
Financing changereported95.2%-703.9%228.8%—
Net cash flowderived638232645
Free cash flowoperating + investing3686,440-727862

Figures in ₹ crore.

Full annual line itemsProfit before tax through closing cash balanceShowHide
Filed order
Profit before tax5705,542330535
Income before WC changes9116801,9001,805
Change in Assets-157-49-2,224-689
Change in Liabilities61-91553777
Change in WC-95-140-1,67188
Cash flow from Operations6564251581,834
Cash flow from Investing-2886,015-885-972
Cash flow from Financing-304-6,3581,053-817
Total Cash Flow638232645
Cash (Start of the year)16582365299
Cash (End of the year)228165697365

Figures in ₹ crore unless the line item is per-share.

08/Ownership

Shareholding pattern

Percentage of total shares by holder category across the last 4 reported quarters. Sort any quarter column to rank holders by size.

Promoters
53.79%
+0.07 pts QoQ
FII
12.26%
+1.95 pts QoQ
DII (other)
0.91%
+0.36 pts QoQ
Mutual funds
20.76%
+4.83 pts QoQ
Retail & others
12.29%
-7.20 pts QoQ
Filed order
Promoters53.8%53.7%40.4%40.4%
FII12.3%10.3%10.5%17.2%
DII (other)0.9%0.6%0.9%1.1%
Mutual funds20.8%15.9%26.7%26.4%
Retail & others12.3%19.5%21.4%14.8%
Promoters — QoQ changepts, derived0.1%13.3%0.0%—
FII — QoQ changepts, derived1.9%-0.2%-6.7%—
DII (other) — QoQ changepts, derived0.4%-0.4%-0.2%—
Mutual funds — QoQ changepts, derived4.8%-10.8%0.3%—
Retail & others — QoQ changepts, derived-7.2%-1.9%6.6%—
Totalderived100.0%100.0%100.0%100.0%

Values are percentages of total outstanding shares; QoQ rows are percentage-point moves.

09/Events

Corporate actions

Dividends, bonuses, splits and rights issues. Filter by type, sort by any date, and expand a row for the full event detail.

DividendInterim₹3.0030.0%02 Apr 202603 Apr 202620 Mar 2026

10/Comparison

Peers & competitors

Competitor set priced live. Filter by sector, sort any column, and expand a peer for its business description.

Sector
APOLLOHOSPApollo Hospitals Enter. LHealthcare Services₹9,200.00+5.29%14.13 L₹1,32,139 Cr$14.68B
MAXHEALTHMAX Healthcare INS LtdHealthcare Services₹1,081.00+3.88%95.32 L₹1,05,080 Cr$11.68B
MANIPALHOSManipal Health Enterpri LHealthcare₹702.20+0.83%11.62 L₹92,366 Cr$10.26B
FORTISFortis Healthcare LtdHealthcare Services₹825.00+1.87%22.88 L₹62,284 Cr$6.92B
MEDANTAGlobal Health LimitedHealthcare Services₹1,480.20+0.13%2.65 L₹39,829 Cr$4.43B
NHNarayana Hrudayalaya Ltd.Healthcare Services₹1,945.00+3.84%7.85 L₹39,757 Cr$4.42B
LALPATHLABDR. LAL Path Labs Ltd.Healthcare Services₹1,989.00+1.31%2.65 L₹33,680 Cr$3.74B
KIMSKrishna Inst Of MED SCI LHealthcare Services₹795.60+3.62%10.44 L₹33,483 Cr$3.72B
SYNGENESyngene International LtdDiversified₹451.70+3.28%25.58 L₹18,240 Cr$2.03B
MOLBIOMolbio Diagnostics LtdHealthcare₹1,495.50-2.02%7.01 L₹17,228 Cr$1.91B

Market cap is the sector-constituent figure reported per peer · Showing 1–10 of 10

1 / 1

11/Coverage

Company news

Articles published in the last seven days, paginated by the provider.

No news in the last seven days

Company news is available for a rolling one-week window.

Full annual line itemsRevenue, other income, expenses, tax, EPS
ShowHide
Filed order
Revenue4,6434,1383,6992,994
Other Income1261482537
Total Revenue4,7694,2873,7243,031
Total Expenses4,1293,7473,4512,824
Profit Before Tax570471261195
Tax1431345736
Profit After Tax427337205160
EPS - Basic7.52107.852.608.54
EPS - Diluted7.52107.852.608.53

This breakdown is available annually, even when the summary above is quarterly. EPS rows are per share.